0000000000369202

AUTHOR

Alice Annalisa Medaglia

0000-0001-5074-070x

showing 9 related works from this author

An emergent infectious disease: Clostridioides difficile infection hospitalizations, 10-year trend in Sicily

2021

Abstract Background Clostridioides difficile is the most common cause of healthcare-associated diarrhoea worldwide and C. difficile infection is an emerging infectious disease. In the US, its rates are monitored trough an active surveillance system, but many European Union member states still lack this, and in Italy no epidemiological data on C. difficile infection are available except for a few single-centre data. Aim To provide data on the C. difficile infection incidence in Sicily (the biggest and 5th most populous region of Italy) during a 10-year period. Methods We revised all the regional standardized discharge forms between 2009 and June 2019 using the code ICD-9 00845 of the Interna…

AdultMaleMicrobiology (medical)medicine.medical_specialtyPediatricsHealth care-associated diarrhoeaDiseaseCommunicable DiseasesClostridioidesEpidemiologyCase fatality ratemedicineHumansmedia_common.cataloged_instanceEuropean unionSicilyAgedmedia_commonCross InfectionOriginal PaperClostridioides difficilebusiness.industryIncidence (epidemiology)CorrectionGeneral Medicinemedicine.diseaseHospitalizationPneumoniaSurveillance of C. difficile.Infectious DiseasesClostridioides difficile infectionInfectious disease (medical specialty)Clostridium InfectionsEmerging infectious diseaseFemaleSurveillance of C. difficilebusinessInfection
researchProduct

Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature

2021

Abstract Objectives To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement. Study design A computerized search was conducted using PubMed. An article was considered eligible if it reported data on pediatric patient(s) with neurological involvement related to SARS-CoV-2 infection. We also described a case of an acute disseminated encephalomyelitis (ADEM) in a 5-year-old girl with SARS-CoV-2 infection: this case was also included in the systematic review. Results Forty-four articles reporting 59 cases of neurological manifestations in pediatric patients were included in our revi…

Pediatricsmedicine.medical_specialtySubarachnoid hemorrhagePneumonia ViralContext (language use)ReviewPediatricsRJ1-570Transverse myelitismedicineHumansChildNervous System DiseaseAutoimmune encephalitisIntracerebral hemorrhageSARS-CoV-2business.industryCranial nervesCOVID-19MeningoencephalitisGeneral Medicinemedicine.diseaseSARS-CoV-2.Acute disseminated encephalomyelitisNervous System DiseasesbusinessHumanItalian Journal of Pediatrics
researchProduct

Molecular Analysis With 16S rRNA PCR/Sanger Sequencing and Molecular Antibiogram Performed on DNA Extracted From Valve Improve Diagnosis and Targeted…

2022

Abstract Background Molecular analysis (MA) on heart valve (HV) improves the microbiologic diagnosis of infectious endocarditis (IE). The main drawback of MA is the lack of antimicrobial susceptibility information. Methods We conducted a prospective cohort observational study of consecutive adult patients from April 2012 to May 2021 who underwent valve surgery at our hospital. The performance of MA, blood cultures (BC) and valve cultures (VC), and the diagnostic and therapeutic impact of MA were evaluated. Molecular antibiogram results were compared to culture-based antimicrobial susceptibility testing (AST). Results A total of 137 patients with definite IE and 52 patients with no IE were e…

16 s and 18 s rRNAMicrobiology (medical)blood culture negative endocarditiInfectious Diseasesmolecular antibiogram.molecular analysiClinical Infectious Diseases
researchProduct

A challenging case of chorioretinitis and skin lesions in a lung transplant recipient

2018

no

infection and infectious agentsmedicine.medical_specialtyinfectious diseaseclinical research/practicecomplication: infectioulung transplantation/pulmonologyBiopsymedicineImmunology and AllergybiopsyPharmacology (medical)Lung transplant recipientTransplantationmedicine.diagnostic_testinfection and infectious agentbusiness.industryChorioretinitisantibiotic: antifungalmedicine.diseaseinfection and infectious agents - fungalDermatologycomplication: infectiousAntibiotics antifungalInfectious disease (medical specialty)Skin lesionbusinessantibiotic: antifungal; biopsy; clinical research/practice; complication: infectious; infection and infectious agents; infection and infectious agents - fungal; infectious disease; lung transplantation/pulmonology; Immunology and Allergy; Transplantation; Pharmacology (medical)American Journal of Transplantation
researchProduct

Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature

2021

Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual…

Pediatricsmedicine.medical_specialtyHeart diseaseSettore MED/17 - Malattie InfettiveDiseaseReviewMucocutaneous Lymph Node SyndromePediatricsRJ1-57003 medical and health sciences0302 clinical medicineRecurrence030225 pediatricsSars-Cov2EpidemiologymedicineHumans030212 general & internal medicineskin and connective tissue diseasesChildPandemicsbusiness.industrySARS-CoV-2Incidence (epidemiology)IncidenceInfantmedicine.diseaseSars-Cov2Coronary arteriesmedicine.anatomical_structureRecurrent Kawasaki diseaseChild PreschoolKawasaki diseaseKawasaki disease recurrenceVasculitisbusinessCovid-19Medical literature
researchProduct

Malassezia restricta Pneumonia in Solid Organ Transplant Recipients: First Report of Two Cases

2021

Emerging fungal infections are a major challenge in solid organ transplantation (SOT) and are associated with high morbidity and mortality. We report two cases of Malassezia restricta pneumonia in SOT recipients. Infections were diagnosed with molecular analysis and histology. Patients were treated with antifungal therapy and have fully recovered.

Microbiology (medical)kidney transplantemerging fungal infectionsEmerging fungal infections; Kidney transplant; Lung transplant; Malassezia restrictaQH301-705.5<i>Malassezia restricta</i>Malassezia restrictaCase ReportPlant ScienceBiology (General)lung transplantEmerging fungal infectionEcology Evolution Behavior and Systematics
researchProduct

Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis

2021

Abstract We describe a challenging case of patient with metallo-beta-lactamase-producing Pseudomonas aeruginosa sternal osteomyelitis following aortic valve replacement with biological prosthesis. The strain exhibited a multidrug-resistance phenotype carrying the blaVIM-1 gene and belonged to the high-risk clone sequence type ST235. The patient was successfully treated with surgical debridement plus antibiotic therapy with ceftazidime/avibactam, aztreonam, and amikacin. Time-kill curves showed that this triple antibiotic combination at 1 × MIC was strongly synergic after 8 h, achieving 99.9% killing and maintaining this until 48 h.

Microbiology (medical)AvibactamDrug ResistanceCeftazidimeInfectious and parasitic diseasesRC109-216Aztreonammedicine.disease_causeST235CeftazidimeMicrobiologyCeftazidime–avibactamchemistry.chemical_compoundAztreonamAortic valve replacementDrug TherapyDrug Resistance Multiple BacterialmedicineHumansPseudomonas InfectionsPseudomonas aeruginosa; ST235; VIM-1; aztreonam; ceftazidime-avibactam; osteomyelitisAmikacinAgedPseudomonas aeruginosabusiness.industryceftazidime-avibactamOsteomyelitisBacterialOsteomyelitisGeneral MedicineCeftazidime/avibactammedicine.diseaseAnti-Bacterial AgentsDrug CombinationsInfectious DiseaseschemistryDebridementAmikacinPseudomonas aeruginosaCombinationVIM-1Drug Therapy CombinationFemalebusinessAzabicyclo CompoundsMultiplemedicine.drug
researchProduct

Intestinal Involvement in Kawasaki Disease

2018

Objectives To describe a case of Kawasaki disease with intestinal involvement and to analyze other published reports to define clinical characteristics, diagnostic issues, and therapeutic approaches of gastrointestinal involvement in Kawasaki disease. Study design A computerized search without language restriction was conducted using PubMed and SCOPUS. An article was considered eligible for inclusion in the systematic review if it reported data on patient(s) with intestinal involvement in Kawasaki disease. Our case was also included in the analysis. Results Thirty-three articles reporting 48 cases of Kawasaki disease with intestinal involvement were considered. Fever, abdominal pain, and vo…

Intestinal pseudo-obstructionMalemedicine.medical_specialtyPediatricsAbdominal painSettore MED/17 - Malattie InfettiveAdolescentFeverMucocutaneous Lymph Node SyndromeDiagnosis Differential03 medical and health sciences0302 clinical medicinepediatric gastroenterology030225 pediatricsmedicineintestinal pseudo-obstructionHumans030212 general & internal medicineHematologic TestPediatric gastroenterologyCoronary artery aneurysmGangreneAspirinHematologic TestsIntestinal Diseasebusiness.industryabdominal painImmunoglobulins Intravenousmedicine.diseasecoronary artery aneurysmHospitalizationIntestinal DiseasesImmunoglobulins IntravenouPediatrics Perinatology and Child HealthKawasakiSplenomegalyVomitingKawasaki diseasemedicine.symptombusinessTomography X-Ray ComputedBowel diseaseIntestinal Obstructionmedicine.drugHepatomegalyHuman
researchProduct

Additional file 1 of Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature

2021

Additional file 1: Supplemental materials. Table 1 Quality Appraisal Checklist for Case Series Studies of IHE. Supplemental materials. Table 2 Checklist for Case Reports of The Joanna Briggs Institute Critical Appraisal tools.

researchProduct